Literature DB >> 25081974

The evolving role of neurological imaging in neuro-oncology.

E J Fontana1, T Benzinger, C Cobbs, J Henson, S J Fouke.   

Abstract

Neuroimaging has played a critical role in the management of patients with neurological disease, since the first ventriculogram was performed in 1918 by Walter Dandy (Mezger et al. Langenbecks Arch Surg 398(4):501-514, 2013). Over the last century, technology has evolved significantly, and within the last decade, the role of imaging in the management of patients with neuro-oncologic disease has shifted from a tool for gross identification of intracranial pathology, to an integral part of real-time neurological surgery. Current neurological imaging provides detailed information about anatomical structure, neurological function, and metabolic and metabolism-important characteristics that help clinicians and surgeons non-invasively manage patients with brain tumors. It is valuable to review the evolution of neurological imaging over the past several decades, focusing on its role in the management of patients with intracranial tumors. Novel neuro-imaging tools and developing technology with the potential to further transform clinical practice will be discussed, as will the key role neurological imaging plays in neurosurgical planning and intraoperative navigation. With increasingly complex imaging modalities creating growing amounts of raw data, validation of techniques, data analysis, and integrating various pieces of imaging data into individual patient management plans, remain significant challenges for clinicians. We thus suggest mechanisms that might ultimately allow for evidence based integration of imaging in the management of patients with neuro-oncologic disease.

Entities:  

Mesh:

Year:  2014        PMID: 25081974     DOI: 10.1007/s11060-014-1505-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  72 in total

1.  Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.

Authors:  H Thomsen; E Steffensen; E-M Larsson
Journal:  Acta Radiol       Date:  2011-11-23       Impact factor: 1.990

2.  Computed medical imaging. Nobel lecture, Decemberr 8, 1979.

Authors:  G N Hounsfield
Journal:  J Comput Assist Tomogr       Date:  1980-10       Impact factor: 1.826

Review 3.  New PET radiopharmaceuticals beyond FDG for brain tumor imaging.

Authors:  B Gulyás; C Halldin
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-04       Impact factor: 2.346

4.  Investigating brain tumor differentiation with diffusion and perfusion metrics at 3T MRI using pattern recognition techniques.

Authors:  Patricia Svolos; Evangelia Tsolaki; Eftychia Kapsalaki; Kyriaki Theodorou; Kostas Fountas; Ioannis Fezoulidis; Ioannis Tsougos
Journal:  Magn Reson Imaging       Date:  2013-07-30       Impact factor: 2.546

5.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

6.  Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

Authors:  N J Patronas; G Di Chiro; R A Brooks; R L DeLaPaz; P L Kornblith; B H Smith; H V Rizzoli; R M Kessler; R G Manning; M Channing; A P Wolf; C M O'Connor
Journal:  Radiology       Date:  1982-09       Impact factor: 11.105

7.  Motor and language DTI Fiber Tracking combined with intraoperative subcortical mapping for surgical removal of gliomas.

Authors:  Lorenzo Bello; Anna Gambini; Antonella Castellano; Giorgio Carrabba; Francesco Acerbi; Enrica Fava; Carlo Giussani; Marcello Cadioli; Valeria Blasi; Alessandra Casarotti; Costanza Papagno; Arun K Gupta; Sergio Gaini; Giuseppe Scotti; Andrea Falini
Journal:  Neuroimage       Date:  2007-08-29       Impact factor: 6.556

8.  Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Authors:  Nancy U Lin; Véronique Diéras; Devchand Paul; Dominique Lossignol; Christos Christodoulou; Hans-Joachim Stemmler; Henri Roché; Minetta C Liu; Richard Greil; Eva Ciruelos; Sibylle Loibl; Stefania Gori; Andrew Wardley; Denise Yardley; Adam Brufsky; Joanne L Blum; Stephen D Rubin; Bernie Dharan; Klaudia Steplewski; Denise Zembryki; Cristina Oliva; Debasish Roychowdhury; Paolo Paoletti; Eric P Winer
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

9.  The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers.

Authors:  Sarah Jost Fouke; Tammie L Benzinger; Mikhail Milchenko; Pamela LaMontagne; Joshua S Shimony; Michael R Chicoine; Keith M Rich; Albert H Kim; Eric C Leuthardt; Bart Keogh; Daniel S Marcus
Journal:  Neurosurgery       Date:  2014-01       Impact factor: 4.654

10.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

Authors:  S Yamada; K Kubota; R Kubota; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

View more
  1 in total

Review 1.  Recent Trends, Technical Concepts and Components of Computer-Assisted Orthopedic Surgery Systems: A Comprehensive Review.

Authors:  Jan Kubicek; Filip Tomanec; Martin Cerny; Dominik Vilimek; Martina Kalova; David Oczka
Journal:  Sensors (Basel)       Date:  2019-11-27       Impact factor: 3.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.